We demonstrated that fisetin decreases migration and invasion in cervical cancer cells possibly by inactivating the p38 MAPK signaling pathway, inhibiting the nuclear translocation and DNA binding activity of NF-κB, and reducing the level of uPA expression, as well as having an anti-metastatic potential. This evidence concerns the gene PLAU and cervical carcinoma.